• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人高血压的病理生理学和治疗进展。

Update on pathophysiology and treatment of hypertension in the elderly.

机构信息

Renal, Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, USA.

出版信息

Curr Hypertens Rep. 2011 Oct;13(5):330-7. doi: 10.1007/s11906-011-0215-x.

DOI:10.1007/s11906-011-0215-x
PMID:21681384
Abstract

Hypertension is common in the elderly, and its prevalence increases with aging. The vascular system is a prototypical aging tissue, and arterial stiffness plays a major role in hypertension as the individual ages. Some unique aging changes in the nitric oxide and angiotensin II pathways are particularly important for vascular aging. Studies focusing on direct measures of vascular stiffness have increased understanding of the pathophysiology behind increased arterial stiffness. Goal blood pressure in the elderly is debated, but based on current outcome data, a goal blood pressure of 150/80-90 mm Hg is reasonable in at least the very elderly. This review discusses in detail the various landmark hypertension studies in the elderly. We recommend use of thiazide diuretics, long-acting calcium channel blockers, and angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers as either monotherapy or in combination, with beta-blockers reserved for patients with specific indications.

摘要

高血压在老年人中很常见,其患病率随着年龄的增长而增加。血管系统是典型的衰老组织,随着个体年龄的增长,动脉僵硬度在高血压中起着重要作用。一氧化氮和血管紧张素 II 途径中的一些独特的衰老变化对血管衰老尤为重要。关注血管僵硬度的直接测量方法的研究增加了对动脉僵硬度增加背后病理生理学的理解。老年患者的目标血压存在争议,但基于目前的结果数据,至少对于非常高龄的患者,将目标血压设定为 150/80-90mmHg 是合理的。这篇综述详细讨论了老年人中的各种标志性高血压研究。我们建议使用噻嗪类利尿剂、长效钙通道阻滞剂和血管紧张素转换酶抑制剂或血管紧张素 II 受体阻滞剂作为单一疗法或联合疗法,将β受体阻滞剂保留给有特定适应证的患者。

相似文献

1
Update on pathophysiology and treatment of hypertension in the elderly.老年人高血压的病理生理学和治疗进展。
Curr Hypertens Rep. 2011 Oct;13(5):330-7. doi: 10.1007/s11906-011-0215-x.
2
Efficacy of various antihypertensive agents as evaluated by indices of vascular stiffness in elderly hypertensive patients.通过血管僵硬度指标评估不同降压药物对老年高血压患者的疗效。
Hypertens Res. 2003 Aug;26(8):609-14. doi: 10.1291/hypres.26.609.
3
Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial.联合治疗与单药治疗作为2期高血压初始治疗的比较:一项基于社区的随机开放标签试验的预设亚组分析
Clin Ther. 2008 Apr;30(4):661-72. doi: 10.1016/j.clinthera.2008.04.013.
4
Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.联合治疗在高血压治疗中的作用:聚焦缬沙坦联合氨氯地平
Adv Ther. 2008 Apr;25(4):300-20. doi: 10.1007/s12325-008-0042-x.
5
Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension.在难治性高血压中加用血管紧张素II受体阻滞剂对动脉波反射和脉压放大的有利影响。
J Hum Hypertens. 2000 Sep;14(9):541-6. doi: 10.1038/sj.jhh.1001053.
6
Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program.缬沙坦对高血压和总体心血管风险的真实世界疗效:一项转化研究计划的综述与启示
Vasc Health Risk Manag. 2011;7:209-35. doi: 10.2147/VHRM.S9434. Epub 2011 Mar 31.
7
Comparison of valsartan 160 mg with lisinopril 20 mg, given as monotherapy or in combination with a diuretic, for the treatment of hypertension: the Blood Pressure Reduction and Tolerability of Valsartan in Comparison with Lisinopril (PREVAIL) study.缬沙坦160毫克与赖诺普利20毫克单药治疗或联合利尿剂治疗高血压的比较:缬沙坦与赖诺普利降压效果及耐受性比较(PREVAIL)研究
Clin Ther. 2004 Jun;26(6):855-65. doi: 10.1016/s0149-2918(04)90129-4.
8
Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients.缬沙坦与硝苯地平控释片对高血压患者全身动脉僵硬度的影响。
Am J Hypertens. 2004 Nov;17(11 Pt 1):1050-5. doi: 10.1016/j.amjhyper.2004.06.028.
9
Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients.在糖尿病高血压患者的动脉上,在先前的抗高血压药物基础上加用血管紧张素受体阻滞剂。
Hypertension. 2006 Aug;48(2):271-7. doi: 10.1161/01.HYP.0000230234.84356.36. Epub 2006 Jun 19.
10
Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.缬沙坦联合氢氯噻嗪与氨氯地平单药治疗对伴有其他心血管危险因素的高血压患者的疗效及耐受性比较:VAST研究
Clin Ther. 2005 May;27(5):578-87. doi: 10.1016/j.clinthera.2005.05.006.

引用本文的文献

1
Centrally acting antihypertensives and alpha-blockers in people at risk of falls: therapeutic dilemmas-a clinical review.中枢作用降压药和 α 受体阻滞剂在有跌倒风险的人群中的应用:治疗困境——临床综述。
Eur Geriatr Med. 2023 Aug;14(4):675-682. doi: 10.1007/s41999-023-00813-x. Epub 2023 Jul 12.
2
White matter changes underlie hypertension-related cognitive decline in older adults.高血压相关认知衰退与老年人的白质变化有关。
Neuroimage Clin. 2023;38:103389. doi: 10.1016/j.nicl.2023.103389. Epub 2023 Mar 29.
3
Noninvasive arterial compliance estimation.

本文引用的文献

1
J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial.重新审视 J 型曲线:TNT 试验中血压与心血管事件的分析。
Eur Heart J. 2010 Dec;31(23):2897-908. doi: 10.1093/eurheartj/ehq328. Epub 2010 Sep 16.
2
Hypertension in the elderly: what is the goal blood pressure target and how can this be attained?老年人高血压:目标血压目标值是多少,以及如何达到这一目标?
Curr Hypertens Rep. 2010 Oct;12(5):331-4. doi: 10.1007/s11906-010-0138-y.
3
Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy.
无创动脉顺应性估计。
Physiol Res. 2021 Dec 30;70(Suppl4):S483-S494. doi: 10.33549/physiolres.934798.
4
Assessment of quality and readability of internet-based health information related to commonly prescribed angiotensin receptor blockers.评估与常用血管紧张素受体阻滞剂相关的基于互联网的健康信息的质量和可读性。
Pan Afr Med J. 2020 Mar 11;35:70. doi: 10.11604/pamj.2020.35.70.18237. eCollection 2020.
5
Psychometric Evaluation of Chinese Version of Adherence to Refills and Medications Scale (ARMS) and Blood-Pressure Control Among Elderly with Hypertension.中文版服药依从性与药物量表(ARMS)的心理测量学评估及老年高血压患者的血压控制情况
Patient Prefer Adherence. 2020 Feb 10;14:213-220. doi: 10.2147/PPA.S236268. eCollection 2020.
6
Persistence with antihypertensives in uncomplicated treatment-naïve very elderly patients: a nationwide population-based study.初治无并发症的高龄患者抗高血压药物的持续性:一项基于全国人群的研究。
BMC Cardiovasc Disord. 2017 Aug 24;17(1):232. doi: 10.1186/s12872-017-0665-4.
7
The effect of slow-loaded breathing training on the blood pressure response to handgrip exercise in patients with isolated systolic hypertension.慢加载呼吸训练对单纯收缩期高血压患者握力运动血压反应的影响。
Hypertens Res. 2017 Oct 5;40(10):885-891. doi: 10.1038/hr.2017.54. Epub 2017 Apr 20.
8
Antihypertensive withdrawal for the prevention of cognitive decline.停用抗高血压药物以预防认知功能减退。
Cochrane Database Syst Rev. 2016 Nov 1;11(11):CD011971. doi: 10.1002/14651858.CD011971.pub2.
9
Association of age and admission mean arterial blood pressure in patients with stroke-data from a national stroke registry.年龄与卒中患者入院平均动脉血压的关联——来自全国卒中登记处的数据
Hypertens Res. 2016 May;39(5):356-61. doi: 10.1038/hr.2015.147. Epub 2016 Jan 7.
10
Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Terms of Major Cardiovascular Disease Outcomes in Elderly Patients: A Nationwide Population-Based Cohort Study.血管紧张素转换酶抑制剂与血管紧张素II受体阻滞剂对老年患者主要心血管疾病结局的比较疗效:一项基于全国人群的队列研究
Medicine (Baltimore). 2015 Oct;94(43):e1751. doi: 10.1097/MD.0000000000001751.
非常高龄高血压合并冠心病患者的血压与预后:INVEST 子研究。
Am J Med. 2010 Aug;123(8):719-26. doi: 10.1016/j.amjmed.2010.02.014.
4
A vascular theory of aging.
J Gerontol A Biol Sci Med Sci. 2010 Oct;65(10):1025-7. doi: 10.1093/gerona/glq135. Epub 2010 Jul 22.
5
Mechanisms of vascular aging: new perspectives.血管老化的机制:新视角。
J Gerontol A Biol Sci Med Sci. 2010 Oct;65(10):1028-41. doi: 10.1093/gerona/glq113. Epub 2010 Jun 24.
6
Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study.治疗老年单纯收缩期高血压的目标血压:缬沙坦老年单纯收缩期高血压研究。
Hypertension. 2010 Aug;56(2):196-202. doi: 10.1161/HYPERTENSIONAHA.109.146035. Epub 2010 Jun 7.
7
"The lower the BP the better" paradigm in the elderly: vanished by VALISH?
Hypertension. 2010 Aug;56(2):182-4. doi: 10.1161/HYPERTENSIONAHA.110.150763. Epub 2010 Jun 7.
8
Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'.健康人群和心血管危险因素存在情况下脉搏波速度的决定因素:“建立正常值和参考值”。
Eur Heart J. 2010 Oct;31(19):2338-50. doi: 10.1093/eurheartj/ehq165. Epub 2010 Jun 7.
9
The "J curve" problem revisited: old and new findings.“J 曲线”问题再探讨:新老发现。
Curr Hypertens Rep. 2010 Aug;12(4):290-5. doi: 10.1007/s11906-010-0121-7.
10
Impact of electrocardiographic left ventricular hypertrophy on the occurrence of cardiovascular events in elderly hypertensive patients. - The Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS) -.心电图左心室肥厚对老年高血压患者心血管事件发生的影响。- 日本老年高血压患者最佳收缩压评估试验(JATOS)-。
Circ J. 2010 May;74(5):938-45. doi: 10.1253/circj.cj-09-0722. Epub 2010 Mar 26.